Aclarion, Inc. ACON
Set alert
At close · Oct 30
After hours · Oct 30, 6:29 PM ET
- YTD
- -57.61%
- 1 year
- -74.77%
- Open
- 2.00
- Prev close
- 1.97
- Mkt cap
- 5.62M
- Vol
- 18.45K
- Avg vol
- 46.32K
- EPS
- -7.38
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.88
- High
- 2.00
- Forward P/E
- -0.24
- Beta
- 0.40
- Short ratio
- 0.77
- Inst. own
- 3.57%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 0.1701
- 200-d avg
- 0.250115
- 1y target
- 1.30
News
-
1 week ago benzinga.com
Aclarion Publishes CEO Letter; Notes Q3 Scan Volumes Up 85% YoY And Up 117% YtD
Shareholder Letter from Chief Executive Officer Brent Ness providing an update on the Company’s momentum and value-creating priorities for the quarter ended September 30, 2026."The third quarter was…
1 month ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market session. The company's market cap stands at $1.2 million. GlucoTrack (NASDAQ:GCTK) stock rose 96.55% to…
1 month ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after-market session. The market value of their outstanding shares is at $1.7 million. Greenland Mines…
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Tempest Therapeutics (NASDAQ:TPST) stock increased by 41.6% to $1.07 during Tuesday's after-market session. The company's market cap stands at $12.9 million. Jupiter Neurosciences…
-
2 months ago benzinga.com
Aclarion Announces University Of Arizona College Of Medicine - Phoenix As New Clinical Site In Its CLARITY Trial
University of Arizona College of Medicine – Phoenix is home to a leading neurosurgery and orthopedic spine program with deep expertise in complex spine surgery and a strong commitment to clinical…
-
2 months ago benzinga.com
Aclarion Says USPTO Issues Notice Of Allowance For U.S. Patent Application Titled Multi-Voxel Prescription For Lumbar Disc Evaluation
Patent protects the precision of MRS data capture within the target disc — a critical step in the Nociscan workflowDesigned to reduce scan time, support faster technologist onboarding and deliver…
-
3 months ago benzinga.com
Aclarion Announces Texas Spine Care Center As New Clinical Site In Chronic Low bAck pain Randomized Independent Trial studY Trial
Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient's pain before recommending treatmentCLARITY is a prospective,…
-
4 months ago benzinga.com
Aclarion Launches Market Access Program In Partnership With PRIA Healthcare
Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion's AI-driven platform for chronic low back pain.Program aims to follow successful reimbursement wins in the UK…
-
4 months ago benzinga.com
Aclarion Board Reviews Echo Lake's Unsolicited Public Proposal And Unanimously Determined To Reject It
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI)…
-
5 months ago benzinga.com
Aclarion Partners With Institute of Neuro Innovation on Back Pain Technology
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI)…
-
5 months ago benzinga.com
Aclarion Announces That Its Nociscan Technology Was Used In A New Research Study Exploring The Biological Factors Associated With Back Pain In Patients With Modic Type 1 Changes
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW))), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI)…
5 months ago benzinga.com
SentinelOne To Rally Nearly 40%? Here Are 10 Analyst Forecasts For Friday
Top Wall Street analysts changed outlook on top names. For full changes, see analyst ratings page. Stock targets and ratings also updated.
-
5 months ago benzinga.com
Ascendiant Capital Maintains Buy on Aclarion, Raises Price Target to $7.5
Ascendiant Capital analyst Lucas Ward maintains Aclarion (NASDAQ:ACON) with a Buy and raises the price target from $7 to $7.5.
-
5 months ago benzinga.com
Echo Lake Capital Offers To Acquire Aclarion At $4.00/Share And Contingent Value Right Representing Right For Stockholders To Receive 80% Of Net Proceeds From Nociscan Sale.
Offers $4.00 per share in cash plus CVRStock currently trades below the value of its cash and other assetsBelieves company's public shell worth at least another $6 million if Board effected a reverse…
-
5 months ago benzinga.com
Aclarion Q1 EPS $(1.34) Beats $(1.55) Estimate, Sales $21.140K Miss $25.000K Estimate
Aclarion (NASDAQ:ACON) reported quarterly losses of $(1.34) per share which beat the analyst consensus estimate of $(1.55) by 13.55 percent. This is a 85.62 percent increase over losses of $(9.32)…
-
5 months ago benzinga.com
Aclarion Adds Lanman Spinal Neurosurgery As Clinical Site In CLARITY Trial
Lanman Spinal Neurosurgery is a leading spine-focused private practice recognized for its expertise in complex spinal procedures, early adoption of innovative technologies and high surgical volumeThe…
-
6 months ago benzinga.com
Aclarion Establishes Second Commercial Agreement With Weill Cornell Medicine; Deal Brings Nociscan To Weill Cornell Medicine And Och Spine At Newyork-Presbyterian/Weill Cornell Medical Center
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI)…
-
6 months ago benzinga.com
Aclarion Announces $2.5M Buyback Plan
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms…
-
6 months ago benzinga.com
Aclarion Secures U.S. Patent Covering Machine Learning–Based Platform For Analyzing Magnetic Resonance Spectroscopy Data
Patent covers use of AI in workflows of future products to accelerate company's ability to scale and enhance already strong gross margins Expands intellectual property portfolio to 64 issued and…
-
6 months ago benzinga.com
Aclarion Signs Commercial Agreement With Weill Cornell Medicine Over Access For Nociscan To Weill Cornell, Och Spine
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI)…
-
7 months ago benzinga.com
Ascendiant Capital Maintains Buy on Aclarion, Lowers Price Target to $7
Ascendiant Capital analyst Lucas Ward maintains Aclarion (NASDAQ:ACON) with a Buy and lowers the price target from $23 to $7.
-
7 months ago benzinga.com
Aclarion Adopts 1-Year Shareholder Rights Plan To Protect Long-Term Value And Prevent Hostile Takeovers
Aclarion, Inc. (NASDAQ:ACON, ACONW))) ("Aclarion" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited duration stockholder rights plan (the…
-
7 months ago benzinga.com
Aclarion Expands AI Tool To Help Doctors Pinpoint Back Pain, Eyes Growth As More Hospitals Adopt Nociscan Technology
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW))), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI)…
-
9 months ago benzinga.com
Aclarion Expands Nociscan Availability In Los Angeles, Partners With Source Healthcare To Support Growth And Real-World Evidence Generation
Expands availability of Nociscan in the greater Los Angeles areaReinforces Nociscan's non-invasive advantage with real-world clinical validation compared to anesthetic discography, a spinal injection…
9 months ago benzinga.com
Aclarion Raises $10.4 Million, Sharpens Focus On Nociscan Rollout
Aclarion, Inc. (NASDAQ: ACON) closed a $10.4 million financing at $5.18/share, boosting balance sheet & extending cash runway to 2028.
-
9 months ago benzinga.com
Aclarion Raises $10.4M, Extends Cash Runway Into 2028
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI)…
-
9 months ago benzinga.com
Is the Market Bullish or Bearish on Aclarion Inc?
Is the Market Bullish or Bearish on Aclarion Inc?
9 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
9 months ago benzinga.com
Dow Edges Higher; US Economy Adds 50,000 Jobs In December
Dow Edges Higher; US Economy Adds 50,000 Jobs In December
9 months ago benzinga.com
WD-40 Posts Downbeat Q1 Results, Joins Olin, AXT And Other Big Stocks Moving Lower In Friday's Pre-Market Session
WD-40 Posts Downbeat Q1 Results, Joins Olin, AXT And Other Big Stocks Moving Lower In Friday's Pre-Market Session
9 months ago benzinga.com
Why Tilray Brands Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
Why Tilray Brands Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
9 months ago benzinga.com
Aclarion's AI Back Pain Tech Sees 114% Surge In Demand, Stock Soars
Aclarion Inc. (NASDAQ: ACON) provided a corporate update on Thursday, reporting strong commercial momentum.
-
9 months ago benzinga.com
Market-Moving News for January 8th
ACON: 54% | Aclarion Reports Triple-Digit Growth for AI Back Pain Platform as Nociscan Adoption Accelerates ACRV: 38% | Acrivon Therapeutics Announces Update On ACR-368 Program, Reports Initial…
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
-
9 months ago benzinga.com
Aclarion Reports Triple-Digit Growth for AI Back Pain Platform as Nociscan Adoption Accelerates
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI)…
11 months ago benzinga.com
Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday
Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday
1 year ago benzinga.com
Why Ericsson Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Why Ericsson Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
1 year ago benzinga.com
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
1 year ago benzinga.com
Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
2 years ago benzinga.com
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 241 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 1214 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Monday's session saw 84 companies set new 52-week lows.